Jaguar Health, Inc. (JAGX) Gross margin 2016–2025
Jaguar Health, Inc. (JAGX) gross margin by fiscal year — reported gross profit divided by reported revenue.
67.2%FY2025 · since FY2016: 63.3% → 67.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 67.2% | -16.1 pp |
| FY2024 | 83.3% | +4.1 pp |
| FY2023 | 79.1% | -4.0 pp |
| FY2022 | 83.1% | +36.9 pp |
| FY2021 | 46.2% | -18.9 pp |
| FY2020 | 65.1% | +31.1 pp |
| FY2019 | 33.9% | -3.4 pp |
| FY2018 | 37.4% | -42.4 pp |
| FY2017 | 79.8% | +16.5 pp |
| FY2016 | 63.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net incomeJAGX Net marginJAGX Gross profitJAGX Operating incomeJAGX Operating marginJAGX Operating cash flowJAGX Free cash flowJAGX Capital expendituresJAGX Return on equityJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Total liabilitiesJAGX Shareholders’ equityJAGX overview →